Difficulty: Medium
Average Score: 68%
Practice
A 54-year-old woman with a history of left-sided breast cancer has been in remission for 5 years following paclitaxel therapy coupled with surgical resection. She has now noticed a new lump in her left breast close to where the original tumor was excised. A biopsy reveals recurring cancer. After talking with her physician, she decided to undergo more chemotherapy. Her physician prescribes a drug, which inhibits DNA topoisomerase. Which chemotherapy agent inhibits topoisomerase?
Correct answer
D
Rationale
The correct answer is D) Irinotecan. Irinotecan inhibits DNA topoisomerase I, an enzyme essential for DNA replication and cell division. By inhibiting this enzyme, irinotecan interferes with cancer cell proliferation, making it an effective chemotherapy agent for treating various cancers, including breast cancer.
Now, let's analyze why the other options are incorrect:
A) Cisplatin: Cisplatin is a platinum-based chemotherapy drug that works by causing DNA cross-linking, leading to cell death. It does not inhibit topoisomerase.
B) Docetaxel: Docetaxel is a taxane chemotherapy drug that acts by disrupting microtubule function in the cell, thereby inhibiting cell division. It does not inhibit topoisomerase.
C) Erlotinib: Erlotinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) pathway in cancer cells. It does not inhibit topoisomerase.
Educational context: Understanding the mechanisms of action of different chemotherapy drugs is crucial in selecting the most appropriate treatment for cancer patients. Knowing which drugs target specific cellular pathways, like topoisomerase inhibition in the case of irinotecan, helps healthcare providers tailor treatment regimens for optimal outcomes. It is important for healthcare professionals to stay updated on the latest research and guidelines to provide evidence-based care to patients undergoing chemotherapy.
Now, let's analyze why the other options are incorrect:
A) Cisplatin: Cisplatin is a platinum-based chemotherapy drug that works by causing DNA cross-linking, leading to cell death. It does not inhibit topoisomerase.
B) Docetaxel: Docetaxel is a taxane chemotherapy drug that acts by disrupting microtubule function in the cell, thereby inhibiting cell division. It does not inhibit topoisomerase.
C) Erlotinib: Erlotinib is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) pathway in cancer cells. It does not inhibit topoisomerase.
Educational context: Understanding the mechanisms of action of different chemotherapy drugs is crucial in selecting the most appropriate treatment for cancer patients. Knowing which drugs target specific cellular pathways, like topoisomerase inhibition in the case of irinotecan, helps healthcare providers tailor treatment regimens for optimal outcomes. It is important for healthcare professionals to stay updated on the latest research and guidelines to provide evidence-based care to patients undergoing chemotherapy.